FL-261

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameFL-261
Drug Alias NameFL-261
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungLung Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesShanghai Full-life Technologies Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Union HospitalShanghai Full-life Technologies Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungLung Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A